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Approximately 90% of the global adult population is
latently infected with Epstein-Barr Virus (EBV). Latent
EBV infections are normally asymptomatic due to a
robust cytotoxic T cell response. However, in the event
of immunosuppression, as observed in HIV/AIDS
patients, these latent infections can lead to B-cell lym-
phomas. In vitro EBV has the capacity to transform pri-
mary B-cells into immortalized Lymphoblastoid Cell
Lines (LCLs). In order to assess changes in both overall
mRNA abundance and mRNA isoform usage, we queried
resting, primary human B cells and LCLs using Human
Exon (HuEx) and conventional Affymetrix U133 arrays.
Using a novel computational algorithm, SplicerEX, we
identified 433 genes whose mRNAs undergo changes in
alternative isoform usage during the transformation from
primary B-cells to LCLs. Isoform changes were largely
orthogonal from expression changes as only ~1/3 of
mRNA isoform changes were also changed at the level of
overall abundance. Isoform changes were classified into
alternative 5’ initiation, internal exclusion/inclusion of
exons, 3’ terminal exon choice, and 3’UTR alterations.
The most striking mRNA isoform change was 3’UTR
shortening, accounting for ~25% of all changes. Gene
ontology analysis of mRNA isoform changes revealed a
strong enrichment for nucleic acid binding proteins,
including splicing and transcription factors. We have
confirmed a subset of the predictions made by SplicerEX
using isoform-specific RT-PCR. Importantly, many
mRNA isoform changes observed were in fact regulated
by EBV latent infection, not just proliferation per se, as
they were also observed in the conversion of EBV-nega-
tive Burkitt’s lymphoma cells (BL41) to latency III
expressing BL41/B95-8 cells. Our preliminary results
further indicate that two transcription factors, the E2
family member TCF4 and the plasma cell differentiation
factor XBP1, are both regulated by EBV at the level of
alternative isoform usage. These proteins both impact
activation of the BZLF1 lytic promoter and our data thus
suggest a novel mechanism by which EBV maintains
latent infection in immortalized B cells. These data may
point to new approaches in regulating the latent/lytic
switch crucial to the pathogenesis of EBV-associated
AIDS lymphomas.
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